Literature DB >> 3285821

Hyperinsulinemia is characterized by jointly disturbed plasma VLDL, LDL, and HDL levels. A population-based study.

M Modan1, H Halkin, A Lusky, P Segal, Z Fuchs, A Chetrit.   

Abstract

Plasma very low density lipoprotein (VLDL) cholesterol and triglyceride, low density lipoprotein (LDL) cholesterol and triglyceridea, high density lipoprotein (HDL) cholesterol, glucose and insulin response (sums of 1- and 2-hour postload oral glucose levels), body mass index (BMI), and blood pressure were determined in a representative sample (n = 542) of the adult Israeli Jewish population. Persons with diabetes or on antihypertensive medications were excluded. Total VLDL and LDL fractions were estimated from their cholesterol and triglyceride subfraction levels that were standardized relative to the mean of the reference group (participants free of glucose intolerance, obesity, and hypertension--the GOH conditions). Hyperinsulinemia and disturbed levels of VLDL and LDL were defined as levels equal to or greater than the 75th percentile and those of HDL, equal to or less than the 25th percentile of their respective reference group distributions. When VLDL was disturbed jointly with LDL and HDL, the mean insulin response adjusted for age, gender, glucose response, BMI, blood pressure, and smoking was high compared to the reference group (166.0 vs. 122.5, p less than 0.001). With isolated disturbed VLDL, or disturbed LDL and HDL but normal VLDL, the mean insulin response resembled the reference group. The adjusted risk ratio for this jointly disturbed lipoprotein profile among hyperinsulinemic individuals was 3.4 (95% confidence limits 2.6 to 4.4, p less than 0.001) with no further association with the GOH conditions. We conclude that hyperinsulinemia is characterized by an atherogenic lipoprotein profile.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3285821     DOI: 10.1161/01.atv.8.3.227

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  12 in total

1.  Insulin resistance, hyperinsulinemia, and cardiovascular disease. The need for novel dietary prevention strategies.

Authors:  H Rupp
Journal:  Basic Res Cardiol       Date:  1992 Mar-Apr       Impact factor: 17.165

2.  Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation.

Authors:  D E Wilson; M Emi; P H Iverius; A Hata; L L Wu; E Hillas; R R Williams; J M Lalouel
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

3.  Association of proinsulin-like molecules with lipids and fibrinogen in non-diabetic subjects--evidence against a modulating role for insulin.

Authors:  V Mohamed-Ali; M M Gould; S Gillies; S Goubet; J S Yudkin; A P Haines
Journal:  Diabetologia       Date:  1995-09       Impact factor: 10.122

4.  Insulin resistance syndrome as a feature of cardiological syndrome X in non-obese men.

Authors:  J W Swan; C Walton; I F Godsland; D Crook; M F Oliver; J C Stevenson
Journal:  Br Heart J       Date:  1994-01

5.  Relationship between plasma plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity: studies in randomly selected normo- and hypertriglyceridaemic men.

Authors:  A Asplund-Carlson; A Hamsten; B Wiman; L A Carlson
Journal:  Diabetologia       Date:  1993-09       Impact factor: 10.122

6.  Association between impaired glucose tolerance and circulating concentration of Lp(a) lipoprotein in relation to coronary heart disease.

Authors:  M Farrer; F L Game; C J Albers; H A Neil; P H Winocour; M F Laker; P C Adams; K G Alberti
Journal:  BMJ       Date:  1993-10-02

7.  Insulin resistance and autonomic function in traumatic lower limb amputees.

Authors:  E Peles; S Akselrod; D S Goldstein; H Nitzan; M Azaria; S Almog; D Dolphin; H Halkin; M Modan
Journal:  Clin Auton Res       Date:  1995-10       Impact factor: 4.435

8.  Interrelationships among measures of autonomic activity and cardiovascular risk factors during orthostasis and the oral glucose tolerance test.

Authors:  E Peles; D S Goldstein; S Akselrod; H Nitzan; M Azaria; S Almog; D Dolphin; H Halkin; M Modan
Journal:  Clin Auton Res       Date:  1995-10       Impact factor: 4.435

9.  Insulin excess counteracts the effects of HDL on intracellular sterol accumulation in cultured human skin fibroblasts.

Authors:  R L Brazg; E L Bierman
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122

10.  The association between insulin sensitivity indices, ECG findings and mortality: a 40-year cohort study.

Authors:  Yonatan Moshkovits; David Rott; Angela Chetrit; Rachel Dankner
Journal:  Cardiovasc Diabetol       Date:  2021-05-06       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.